nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—SLC22A3—Estradiol—osteoporosis	0.173	0.293	CbGbCtD
Adefovir Dipivoxil—ABCC4—Conjugated Estrogens—osteoporosis	0.16	0.271	CbGbCtD
Adefovir Dipivoxil—SLC22A8—Conjugated Estrogens—osteoporosis	0.1	0.169	CbGbCtD
Adefovir Dipivoxil—SLC22A8—Estradiol—osteoporosis	0.0879	0.149	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Conjugated Estrogens—osteoporosis	0.0697	0.118	CbGbCtD
Adefovir Dipivoxil—ABCC4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00834	0.0659	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Nucleotide metabolism—PNP—osteoporosis	0.00659	0.0521	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Nucleotide metabolism—ATIC—osteoporosis	0.00659	0.0521	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—PRDX3—osteoporosis	0.00494	0.039	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Nucleotide metabolism—ATIC—osteoporosis	0.00456	0.0361	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Nucleotide metabolism—PNP—osteoporosis	0.00456	0.0361	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—PRDX3—osteoporosis	0.00374	0.0296	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Nucleotide metabolism—ATIC—osteoporosis	0.00346	0.0273	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Nucleotide metabolism—PNP—osteoporosis	0.00346	0.0273	CbGpPWpGaD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—RAP1A—osteoporosis	0.00346	0.0273	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—GAPDH—osteoporosis	0.0025	0.0197	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—ENO1—osteoporosis	0.00197	0.0155	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Synaptic Vesicle Pathway—PARK7—osteoporosis	0.00196	0.0155	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—GAPDH—osteoporosis	0.00189	0.015	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Nucleotide metabolism—GPX1—osteoporosis	0.00187	0.0147	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00186	1	CbGdCrCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—WDR1—osteoporosis	0.00167	0.0132	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.0016	0.0126	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—ENO1—osteoporosis	0.00149	0.0118	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.00133	0.0105	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—CAP1—osteoporosis	0.00132	0.0105	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Nucleotide metabolism—GPX1—osteoporosis	0.00129	0.0102	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.00126	0.00997	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Nucleotide metabolism—GPX1—osteoporosis	0.00098	0.00775	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.000972	0.00768	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—PLEK—osteoporosis	0.000962	0.0076	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.000916	0.00724	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00091	0.00719	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—TLN1—osteoporosis	0.000829	0.00655	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—PKM—osteoporosis	0.000825	0.00652	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—VCL—osteoporosis	0.000818	0.00646	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.00079	0.00624	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—PGLS—osteoporosis	0.000782	0.00618	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.000779	0.00616	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000743	0.00587	CbGpPWpGaD
Adefovir Dipivoxil—Chest pain—Ibandronate—osteoporosis	0.000693	0.00247	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Ibandronate—osteoporosis	0.000693	0.00247	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—PKM—osteoporosis	0.00069	0.00545	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—FDPS—osteoporosis	0.00069	0.00545	CbGpPWpGaD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000688	0.00245	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Estradiol—osteoporosis	0.000688	0.00245	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Ethinyl Estradiol—osteoporosis	0.000688	0.00245	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Estropipate—osteoporosis	0.00068	0.00242	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.000679	0.00242	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Calcitriol—osteoporosis	0.000679	0.00242	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Calcitriol—osteoporosis	0.000679	0.00242	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.000674	0.00533	CbGpPWpGaD
Adefovir Dipivoxil—Sinusitis—Conjugated Estrogens—osteoporosis	0.000674	0.0024	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Estropipate—osteoporosis	0.000673	0.0024	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Risedronate—osteoporosis	0.000671	0.00239	CcSEcCtD
Adefovir Dipivoxil—Back pain—Ethinyl Estradiol—osteoporosis	0.000666	0.00237	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Risedronate—osteoporosis	0.000661	0.00236	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Zoledronate—osteoporosis	0.000661	0.00236	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Raloxifene—osteoporosis	0.000658	0.00235	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Zoledronate—osteoporosis	0.000658	0.00235	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Estradiol—osteoporosis	0.000658	0.00234	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Raloxifene—osteoporosis	0.000657	0.00234	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Zoledronate—osteoporosis	0.000656	0.00234	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000655	0.00234	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—PGLS—osteoporosis	0.000654	0.00517	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GPD2—osteoporosis	0.000654	0.00517	CbGpPWpGaD
Adefovir Dipivoxil—Skin disorder—Raloxifene—osteoporosis	0.000652	0.00232	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Ibandronate—osteoporosis	0.000652	0.00232	CcSEcCtD
Adefovir Dipivoxil—Back pain—Risedronate—osteoporosis	0.000649	0.00231	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000648	0.00512	CbGpPWpGaD
Adefovir Dipivoxil—Skin disorder—Ibandronate—osteoporosis	0.000646	0.0023	CcSEcCtD
Adefovir Dipivoxil—Nausea—Ergocalciferol—osteoporosis	0.00064	0.00228	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Conjugated Estrogens—osteoporosis	0.00064	0.00228	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Pamidronate—osteoporosis	0.000638	0.00227	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Etidronic acid—osteoporosis	0.000633	0.00226	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Calcitriol—osteoporosis	0.000632	0.00225	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Estradiol—osteoporosis	0.000632	0.00225	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000631	0.00225	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000622	0.00222	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Risedronate—osteoporosis	0.00062	0.00221	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Calcitriol—osteoporosis	0.00062	0.00221	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—FGA—osteoporosis	0.00062	0.0049	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Pamidronate—osteoporosis	0.000617	0.0022	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000612	0.00218	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Estropipate—osteoporosis	0.00061	0.00217	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000605	0.00216	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Alendronate—osteoporosis	0.000601	0.00214	CcSEcCtD
Adefovir Dipivoxil—Cough—Ethinyl Estradiol—osteoporosis	0.000601	0.00214	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Estropipate—osteoporosis	0.000598	0.00213	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—PNP—osteoporosis	0.000598	0.00473	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—ATIC—osteoporosis	0.000598	0.00473	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000593	0.00211	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Raloxifene—osteoporosis	0.000591	0.00211	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.00059	0.00467	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Pamidronate—osteoporosis	0.00059	0.0021	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000587	0.00464	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Risedronate—osteoporosis	0.000586	0.00209	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Ibandronate—osteoporosis	0.000585	0.00209	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Estradiol—osteoporosis	0.000583	0.00208	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Zoledronate—osteoporosis	0.000583	0.00208	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000582	0.00207	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00058	0.00207	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Ibandronate—osteoporosis	0.000578	0.00206	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000574	0.00205	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Risedronate—osteoporosis	0.000571	0.00204	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Risedronate—osteoporosis	0.000571	0.00204	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000567	0.00202	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Etidronic acid—osteoporosis	0.000567	0.00202	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Estropipate—osteoporosis	0.000567	0.00202	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Calcitriol—osteoporosis	0.000566	0.00202	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—FGB—osteoporosis	0.000564	0.00446	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Zoledronate—osteoporosis	0.000564	0.00201	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Conjugated Estrogens—osteoporosis	0.000561	0.002	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Estradiol—osteoporosis	0.00056	0.002	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Alendronate—osteoporosis	0.000558	0.00199	CcSEcCtD
Adefovir Dipivoxil—Cough—Pamidronate—osteoporosis	0.000557	0.00198	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Conjugated Estrogens—osteoporosis	0.000553	0.00197	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000551	0.00196	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Raloxifene—osteoporosis	0.000549	0.00196	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Etidronic acid—osteoporosis	0.000548	0.00195	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Estradiol—osteoporosis	0.000548	0.00195	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Estropipate—osteoporosis	0.000548	0.00195	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Estropipate—osteoporosis	0.000548	0.00195	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—MYC—osteoporosis	0.000546	0.00432	CbGpPWpGaD
Adefovir Dipivoxil—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000546	0.00195	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Estradiol—osteoporosis	0.000543	0.00194	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Ibandronate—osteoporosis	0.000543	0.00194	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Pamidronate—osteoporosis	0.000543	0.00194	CcSEcCtD
Adefovir Dipivoxil—Back pain—Conjugated Estrogens—osteoporosis	0.000543	0.00193	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Alendronate—osteoporosis	0.00054	0.00192	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Alendronate—osteoporosis	0.00054	0.00192	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Estradiol—osteoporosis	0.000539	0.00192	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Zoledronate—osteoporosis	0.000539	0.00192	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Risedronate—osteoporosis	0.000537	0.00191	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000537	0.00425	CbGpPWpGaD
Adefovir Dipivoxil—Skin disorder—Risedronate—osteoporosis	0.000532	0.0019	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Calcitriol—osteoporosis	0.000532	0.0019	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Raloxifene—osteoporosis	0.000531	0.00189	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Raloxifene—osteoporosis	0.000531	0.00189	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Ibandronate—osteoporosis	0.000525	0.00187	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Ibandronate—osteoporosis	0.000525	0.00187	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Estradiol—osteoporosis	0.000516	0.00184	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Calcitriol—osteoporosis	0.000514	0.00183	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Calcitriol—osteoporosis	0.000514	0.00183	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Estradiol—osteoporosis	0.000512	0.00183	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Pamidronate—osteoporosis	0.000511	0.00182	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Pamidronate—osteoporosis	0.00051	0.00182	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Estradiol—osteoporosis	0.000509	0.00182	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Etidronic acid—osteoporosis	0.000509	0.00182	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—OXCT1—osteoporosis	0.000509	0.00402	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CA2—osteoporosis	0.000509	0.00402	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Zoledronate—osteoporosis	0.000508	0.00181	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Estradiol—osteoporosis	0.000507	0.00181	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Estradiol—osteoporosis	0.000506	0.0018	CcSEcCtD
Adefovir Dipivoxil—Rash—Etidronic acid—osteoporosis	0.000505	0.0018	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Etidronic acid—osteoporosis	0.000505	0.0018	CcSEcCtD
Adefovir Dipivoxil—Headache—Etidronic acid—osteoporosis	0.000502	0.00179	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000499	0.00178	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Estropipate—osteoporosis	0.000497	0.00177	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Pamidronate—osteoporosis	0.000496	0.00177	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Zoledronate—osteoporosis	0.000496	0.00177	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Zoledronate—osteoporosis	0.000496	0.00177	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—MGLL—osteoporosis	0.000496	0.00392	CbGpPWpGaD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000493	0.00176	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Estropipate—osteoporosis	0.00049	0.00175	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Alendronate—osteoporosis	0.00049	0.00175	CcSEcCtD
Adefovir Dipivoxil—Cough—Conjugated Estrogens—osteoporosis	0.00049	0.00175	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000485	0.00173	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Alendronate—osteoporosis	0.000483	0.00172	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Risedronate—osteoporosis	0.000482	0.00172	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—PKM—osteoporosis	0.000478	0.00378	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—FDPS—osteoporosis	0.000478	0.00378	CbGpPWpGaD
Adefovir Dipivoxil—Chest pain—Conjugated Estrogens—osteoporosis	0.000478	0.0017	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Conjugated Estrogens—osteoporosis	0.000478	0.0017	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Ibandronate—osteoporosis	0.000477	0.0017	CcSEcCtD
Adefovir Dipivoxil—Nausea—Etidronic acid—osteoporosis	0.000476	0.0017	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000474	0.00169	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000474	0.00169	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Estropipate—osteoporosis	0.000474	0.00169	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Risedronate—osteoporosis	0.000473	0.00169	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Ibandronate—osteoporosis	0.00047	0.00168	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Alendronate—osteoporosis	0.000467	0.00167	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Calcitriol—osteoporosis	0.000467	0.00166	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000466	0.00369	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Zoledronate—osteoporosis	0.000466	0.00166	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Zoledronate—osteoporosis	0.000466	0.00166	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Zoledronate—osteoporosis	0.000462	0.00165	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Calcitriol—osteoporosis	0.00046	0.00164	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000459	0.00164	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Raloxifene—osteoporosis	0.000459	0.00164	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Pamidronate—osteoporosis	0.000458	0.00163	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Ibandronate—osteoporosis	0.000455	0.00162	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—GPD2—osteoporosis	0.000453	0.00358	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PGLS—osteoporosis	0.000453	0.00358	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Zoledronate—osteoporosis	0.000453	0.00162	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Pamidronate—osteoporosis	0.000453	0.00161	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000449	0.0016	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000449	0.0016	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Estradiol—osteoporosis	0.000449	0.0016	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Risedronate—osteoporosis	0.000448	0.0016	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Calcitriol—osteoporosis	0.000445	0.00159	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Conjugated Estrogens—osteoporosis	0.000445	0.00159	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000444	0.00158	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000444	0.00158	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Estradiol—osteoporosis	0.000442	0.00158	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Estropipate—osteoporosis	0.000441	0.00157	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—TNFRSF11B—osteoporosis	0.000438	0.00346	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Estropipate—osteoporosis	0.000437	0.00156	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Estropipate—osteoporosis	0.000437	0.00156	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Conjugated Estrogens—osteoporosis	0.000436	0.00156	CcSEcCtD
Adefovir Dipivoxil—Back pain—Estradiol—osteoporosis	0.000434	0.00155	CcSEcCtD
Adefovir Dipivoxil—Headache—Estropipate—osteoporosis	0.000434	0.00155	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Alendronate—osteoporosis	0.000434	0.00155	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000433	0.00154	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Risedronate—osteoporosis	0.000433	0.00154	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Risedronate—osteoporosis	0.000433	0.00154	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—NFATC1—osteoporosis	0.000431	0.00341	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Alendronate—osteoporosis	0.00043	0.00153	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Alendronate—osteoporosis	0.00043	0.00153	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—TPI1—osteoporosis	0.000428	0.00339	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Alendronate—osteoporosis	0.000428	0.00152	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Raloxifene—osteoporosis	0.000427	0.00152	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000427	0.00337	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Pamidronate—osteoporosis	0.000426	0.00152	CcSEcCtD
Adefovir Dipivoxil—Rash—Raloxifene—osteoporosis	0.000423	0.00151	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Raloxifene—osteoporosis	0.000423	0.00151	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Ibandronate—osteoporosis	0.000423	0.00151	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—IDH2—osteoporosis	0.000422	0.00333	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Raloxifene—osteoporosis	0.000421	0.0015	CcSEcCtD
Adefovir Dipivoxil—Rash—Ibandronate—osteoporosis	0.000419	0.00149	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Ibandronate—osteoporosis	0.000419	0.00149	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Zoledronate—osteoporosis	0.000419	0.00149	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000417	0.00149	CcSEcCtD
Adefovir Dipivoxil—Headache—Ibandronate—osteoporosis	0.000416	0.00148	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—ATIC—osteoporosis	0.000415	0.00328	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PNP—osteoporosis	0.000415	0.00328	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—MYC—osteoporosis	0.000414	0.00327	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Calcitriol—osteoporosis	0.000414	0.00147	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Zoledronate—osteoporosis	0.000413	0.00147	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—WNT1—osteoporosis	0.000412	0.00326	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Estropipate—osteoporosis	0.000412	0.00147	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Pamidronate—osteoporosis	0.000412	0.00147	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Pamidronate—osteoporosis	0.000412	0.00147	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000411	0.00146	CcSEcCtD
Adefovir Dipivoxil—Rash—Calcitriol—osteoporosis	0.00041	0.00146	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Calcitriol—osteoporosis	0.00041	0.00146	CcSEcCtD
Adefovir Dipivoxil—Headache—Calcitriol—osteoporosis	0.000408	0.00145	CcSEcCtD
Adefovir Dipivoxil—Nausea—Alendronate—osteoporosis	0.000405	0.00145	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000403	0.00144	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Ethinyl Estradiol—osteoporosis	0.000403	0.00144	CcSEcCtD
Adefovir Dipivoxil—Nausea—Raloxifene—osteoporosis	0.000399	0.00142	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000398	0.00142	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Ethinyl Estradiol—osteoporosis	0.000397	0.00142	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—CYP27A1—osteoporosis	0.000396	0.00313	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—GAPDH—osteoporosis	0.000395	0.00313	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000395	0.00141	CcSEcCtD
Adefovir Dipivoxil—Nausea—Ibandronate—osteoporosis	0.000395	0.00141	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Risedronate—osteoporosis	0.000393	0.0014	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000393	0.0031	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Estradiol—osteoporosis	0.000392	0.0014	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Zoledronate—osteoporosis	0.000389	0.00139	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Risedronate—osteoporosis	0.000387	0.00138	CcSEcCtD
Adefovir Dipivoxil—Nausea—Calcitriol—osteoporosis	0.000386	0.00138	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—ACP5—osteoporosis	0.000386	0.00305	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000384	0.00137	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Hemostasis—WDR1—osteoporosis	0.000383	0.00303	CbGpPWpGaD
Adefovir Dipivoxil—Chest pain—Estradiol—osteoporosis	0.000382	0.00136	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Estradiol—osteoporosis	0.000382	0.00136	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00038	0.00135	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Zoledronate—osteoporosis	0.000376	0.00134	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Zoledronate—osteoporosis	0.000376	0.00134	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Risedronate—osteoporosis	0.000375	0.00134	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000374	0.00134	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Pamidronate—osteoporosis	0.000374	0.00133	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Pamidronate—osteoporosis	0.000368	0.00131	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000368	0.00291	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000363	0.00287	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PKM—osteoporosis	0.000362	0.00286	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—FDPS—osteoporosis	0.000362	0.00286	CbGpPWpGaD
Adefovir Dipivoxil—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000362	0.00129	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000362	0.00129	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Estradiol—osteoporosis	0.000359	0.00128	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—TPI1—osteoporosis	0.000358	0.00283	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Ethinyl Estradiol—osteoporosis	0.000357	0.00127	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Pamidronate—osteoporosis	0.000356	0.00127	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Estradiol—osteoporosis	0.000356	0.00127	CcSEcCtD
Adefovir Dipivoxil—Rash—Ethinyl Estradiol—osteoporosis	0.000354	0.00126	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000354	0.00126	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—CA2—osteoporosis	0.000353	0.00279	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—OXCT1—osteoporosis	0.000353	0.00279	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Ethinyl Estradiol—osteoporosis	0.000352	0.00125	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Risedronate—osteoporosis	0.000348	0.00124	CcSEcCtD
Adefovir Dipivoxil—Rash—Risedronate—osteoporosis	0.000345	0.00123	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Risedronate—osteoporosis	0.000345	0.00123	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—MGLL—osteoporosis	0.000344	0.00272	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PGLS—osteoporosis	0.000344	0.00272	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GPD2—osteoporosis	0.000344	0.00272	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Risedronate—osteoporosis	0.000343	0.00122	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Zoledronate—osteoporosis	0.000341	0.00122	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.00034	0.00269	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—P4HB—osteoporosis	0.000337	0.00266	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Zoledronate—osteoporosis	0.000336	0.0012	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000334	0.00119	CcSEcCtD
Adefovir Dipivoxil—Nausea—Ethinyl Estradiol—osteoporosis	0.000334	0.00119	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Pamidronate—osteoporosis	0.000331	0.00118	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—GAPDH—osteoporosis	0.000331	0.00261	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Conjugated Estrogens—osteoporosis	0.000329	0.00117	CcSEcCtD
Adefovir Dipivoxil—Rash—Pamidronate—osteoporosis	0.000328	0.00117	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Pamidronate—osteoporosis	0.000328	0.00117	CcSEcCtD
Adefovir Dipivoxil—Headache—Pamidronate—osteoporosis	0.000326	0.00116	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Zoledronate—osteoporosis	0.000325	0.00116	CcSEcCtD
Adefovir Dipivoxil—Nausea—Risedronate—osteoporosis	0.000325	0.00116	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Conjugated Estrogens—osteoporosis	0.000324	0.00116	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—AGER—osteoporosis	0.000323	0.00255	CbGpPWpGaD
Adefovir Dipivoxil—Dyspepsia—Estradiol—osteoporosis	0.000323	0.00115	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—RAP1A—osteoporosis	0.000322	0.00255	CbGpPWpGaD
Adefovir Dipivoxil—Decreased appetite—Estradiol—osteoporosis	0.000319	0.00114	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Estradiol—osteoporosis	0.000316	0.00113	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—PNP—osteoporosis	0.000314	0.00248	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ATIC—osteoporosis	0.000314	0.00248	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000313	0.00112	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—ENO1—osteoporosis	0.000311	0.00246	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Pamidronate—osteoporosis	0.000309	0.0011	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000303	0.0024	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CAP1—osteoporosis	0.000303	0.00239	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Zoledronate—osteoporosis	0.000302	0.00108	CcSEcCtD
Adefovir Dipivoxil—Rash—Zoledronate—osteoporosis	0.0003	0.00107	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Estradiol—osteoporosis	0.0003	0.00107	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Zoledronate—osteoporosis	0.0003	0.00107	CcSEcCtD
Adefovir Dipivoxil—Headache—Zoledronate—osteoporosis	0.000298	0.00106	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—IDH2—osteoporosis	0.000292	0.00231	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Conjugated Estrogens—osteoporosis	0.000291	0.00104	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Estradiol—osteoporosis	0.00029	0.00103	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Estradiol—osteoporosis	0.00029	0.00103	CcSEcCtD
Adefovir Dipivoxil—Rash—Conjugated Estrogens—osteoporosis	0.000289	0.00103	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Conjugated Estrogens—osteoporosis	0.000288	0.00103	CcSEcCtD
Adefovir Dipivoxil—Headache—Conjugated Estrogens—osteoporosis	0.000287	0.00102	CcSEcCtD
Adefovir Dipivoxil—Nausea—Zoledronate—osteoporosis	0.000282	0.00101	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000275	0.00217	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYP27A1—osteoporosis	0.000275	0.00217	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000275	0.00217	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Conjugated Estrogens—osteoporosis	0.000272	0.00097	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—ACP5—osteoporosis	0.000267	0.00211	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—OXCT1—osteoporosis	0.000267	0.00211	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CA2—osteoporosis	0.000267	0.00211	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Estradiol—osteoporosis	0.000263	0.000937	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—MGLL—osteoporosis	0.00026	0.00206	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—ENO1—osteoporosis	0.00026	0.00206	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Estradiol—osteoporosis	0.000259	0.000924	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—PSMA5—osteoporosis	0.000257	0.00203	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PSMA2—osteoporosis	0.000257	0.00203	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—IGF1—osteoporosis	0.000255	0.00202	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Estradiol—osteoporosis	0.000251	0.000894	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.00025	0.00198	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—TPI1—osteoporosis	0.000248	0.00196	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000243	0.00192	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MGLL—osteoporosis	0.00024	0.0019	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SOST—osteoporosis	0.000234	0.00185	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PKM—osteoporosis	0.000234	0.00185	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—P4HB—osteoporosis	0.000234	0.00185	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Estradiol—osteoporosis	0.000233	0.000831	CcSEcCtD
Adefovir Dipivoxil—Rash—Estradiol—osteoporosis	0.000231	0.000824	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Estradiol—osteoporosis	0.000231	0.000823	CcSEcCtD
Adefovir Dipivoxil—Headache—Estradiol—osteoporosis	0.00023	0.000819	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—GAPDH—osteoporosis	0.000229	0.00181	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—AGER—osteoporosis	0.000224	0.00177	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—RAP1A—osteoporosis	0.000223	0.00176	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ANTXR2—osteoporosis	0.000222	0.00175	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PGLS—osteoporosis	0.000222	0.00175	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—IDH2—osteoporosis	0.000221	0.00175	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.00022	0.00174	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ANXA2—osteoporosis	0.00022	0.00174	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PLEK—osteoporosis	0.00022	0.00174	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Estradiol—osteoporosis	0.000218	0.000776	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—CYP27A1—osteoporosis	0.000208	0.00165	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CYP19A1—osteoporosis	0.000208	0.00165	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000204	0.00161	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000204	0.00161	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ACP5—osteoporosis	0.000203	0.0016	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000199	0.00157	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—FDPS—osteoporosis	0.000196	0.00155	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PKM—osteoporosis	0.000196	0.00155	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.00019	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.00019	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TLN1—osteoporosis	0.00019	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—GSN—osteoporosis	0.000188	0.00149	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—TPI1—osteoporosis	0.000188	0.00149	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VCL—osteoporosis	0.000187	0.00148	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GPD2—osteoporosis	0.000186	0.00147	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PGLS—osteoporosis	0.000186	0.00147	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ENO1—osteoporosis	0.000181	0.00143	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PSMA5—osteoporosis	0.000178	0.00141	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PSMA2—osteoporosis	0.000178	0.00141	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—P4HB—osteoporosis	0.000177	0.0014	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GAPDH—osteoporosis	0.000174	0.00137	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—ADCY5—osteoporosis	0.00017	0.00134	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PNP—osteoporosis	0.00017	0.00134	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ATIC—osteoporosis	0.00017	0.00134	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GPX1—osteoporosis	0.00017	0.00134	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—RAP1A—osteoporosis	0.000169	0.00134	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000166	0.00131	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—LRP5—osteoporosis	0.000164	0.0013	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PKM—osteoporosis	0.000157	0.00124	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—FDPS—osteoporosis	0.000157	0.00124	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—LRP6—osteoporosis	0.000157	0.00124	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—MTHFR—osteoporosis	0.000156	0.00124	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—RAP1A—osteoporosis	0.000156	0.00123	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—TGFB1—osteoporosis	0.000153	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—RPL24—osteoporosis	0.000151	0.00119	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—LTF—osteoporosis	0.000151	0.00119	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GPD2—osteoporosis	0.000149	0.00118	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PGLS—osteoporosis	0.000149	0.00118	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.000146	0.00115	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYP19A1—osteoporosis	0.000144	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CA2—osteoporosis	0.000144	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—OXCT1—osteoporosis	0.000144	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—FGA—osteoporosis	0.000142	0.00112	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MGLL—osteoporosis	0.000141	0.00111	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ENO1—osteoporosis	0.000137	0.00108	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—TGFB1—osteoporosis	0.000136	0.00108	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ATIC—osteoporosis	0.000136	0.00108	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PNP—osteoporosis	0.000136	0.00108	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PSMA2—osteoporosis	0.000135	0.00107	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PSMA5—osteoporosis	0.000135	0.00107	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ACP5—osteoporosis	0.000131	0.00103	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—FGB—osteoporosis	0.000129	0.00102	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—POMC—osteoporosis	0.000125	0.000989	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TPI1—osteoporosis	0.000121	0.00096	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—IDH2—osteoporosis	0.00012	0.000945	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ADCY5—osteoporosis	0.000118	0.000932	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GPX1—osteoporosis	0.000117	0.000929	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CA2—osteoporosis	0.000116	0.000915	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—OXCT1—osteoporosis	0.000116	0.000915	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—P4HB—osteoporosis	0.000114	0.000902	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000113	0.000895	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MGLL—osteoporosis	0.000113	0.000891	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP27A1—osteoporosis	0.000112	0.000889	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—GAPDH—osteoporosis	0.000112	0.000885	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ACP5—osteoporosis	0.000109	0.000864	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP19A1—osteoporosis	0.000109	0.000864	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—MTHFR—osteoporosis	0.000108	0.000857	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NFATC1—osteoporosis	0.000106	0.000841	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—DKK1—osteoporosis	0.000106	0.000835	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000103	0.000814	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—WNT1—osteoporosis	0.000102	0.000804	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TPI1—osteoporosis	0.000102	0.000804	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—MYC—osteoporosis	9.92e-05	0.000784	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGA—osteoporosis	9.9e-05	0.000782	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—IDH2—osteoporosis	9.59e-05	0.000758	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—P4HB—osteoporosis	9.56e-05	0.000756	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—TGFB1—osteoporosis	9.46e-05	0.000747	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GAPDH—osteoporosis	9.38e-05	0.000742	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—RAP1A—osteoporosis	9.14e-05	0.000722	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP27A1—osteoporosis	9.02e-05	0.000713	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ADCY5—osteoporosis	8.94e-05	0.000706	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GPX1—osteoporosis	8.9e-05	0.000704	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ENO1—osteoporosis	8.82e-05	0.000697	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ACP5—osteoporosis	8.77e-05	0.000693	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PSMA5—osteoporosis	8.69e-05	0.000687	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PSMA2—osteoporosis	8.69e-05	0.000687	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—POMC—osteoporosis	8.67e-05	0.000685	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.26e-05	0.000653	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—MTHFR—osteoporosis	8.22e-05	0.00065	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TPI1—osteoporosis	8.15e-05	0.000645	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CALCA—osteoporosis	8.1e-05	0.00064	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—P4HB—osteoporosis	7.67e-05	0.000606	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GAPDH—osteoporosis	7.53e-05	0.000595	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.45e-05	0.000589	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ENO1—osteoporosis	7.39e-05	0.000584	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KL—osteoporosis	7.35e-05	0.000581	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—RAP1A—osteoporosis	7.33e-05	0.000579	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PSMA5—osteoporosis	7.28e-05	0.000575	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PSMA2—osteoporosis	7.28e-05	0.000575	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.14e-05	0.000564	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	6.79e-05	0.000537	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—POMC—osteoporosis	6.57e-05	0.000519	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.22e-05	0.000491	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ENO1—osteoporosis	5.92e-05	0.000468	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP19A1—osteoporosis	5.91e-05	0.000467	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PSMA5—osteoporosis	5.84e-05	0.000461	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PSMA2—osteoporosis	5.84e-05	0.000461	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IGF1—osteoporosis	5.84e-05	0.000461	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ADCY5—osteoporosis	5.76e-05	0.000455	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MTHFR—osteoporosis	5.3e-05	0.000419	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IRS2—osteoporosis	5.04e-05	0.000398	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ADCY5—osteoporosis	4.83e-05	0.000381	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GPX1—osteoporosis	4.81e-05	0.00038	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP19A1—osteoporosis	4.74e-05	0.000374	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MTHFR—osteoporosis	4.44e-05	0.000351	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IRS1—osteoporosis	4.4e-05	0.000348	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL6R—osteoporosis	4.13e-05	0.000327	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ADCY5—osteoporosis	3.87e-05	0.000306	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GPX1—osteoporosis	3.86e-05	0.000305	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MTHFR—osteoporosis	3.56e-05	0.000281	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—POMC—osteoporosis	3.55e-05	0.000281	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TGFB1—osteoporosis	3.5e-05	0.000277	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—POMC—osteoporosis	2.85e-05	0.000225	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MYC—osteoporosis	2.45e-05	0.000194	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFB1—osteoporosis	2.44e-05	0.000193	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL6—osteoporosis	1.84e-05	0.000146	CbGpPWpGaD
